180 related articles for article (PubMed ID: 32300202)
1. CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer.
Ball MS; Bhandari R; Torres GM; Martyanov V; ElTanbouly MA; Archambault K; Whitfield ML; Liby KT; Pioli PA
Sci Rep; 2020 Apr; 10(1):6560. PubMed ID: 32300202
[TBL] [Abstract][Full Text] [Related]
2. CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages.
Ball MS; Shipman EP; Kim H; Liby KT; Pioli PA
PLoS One; 2016; 11(2):e0149600. PubMed ID: 26918785
[TBL] [Abstract][Full Text] [Related]
3. T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages.
Torres GM; Yang H; Park C; Spezza PA; Khatwani N; Bhandari R; Liby KT; Pioli PA
Front Immunol; 2022; 13():768753. PubMed ID: 35265066
[TBL] [Abstract][Full Text] [Related]
4. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
Li M; Sun K; Redelman D; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):739-50. PubMed ID: 20338256
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.
Zhao Y; Huo M; Xu Z; Wang Y; Huang L
Biomaterials; 2015 Nov; 68():54-66. PubMed ID: 26264646
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; Lamph WW; Vannini N; Sogno I; Albini A; Sporn MB
Clin Cancer Res; 2008 Jul; 14(14):4556-63. PubMed ID: 18628471
[TBL] [Abstract][Full Text] [Related]
7. The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge.
Auletta JJ; Alabran JL; Kim BG; Meyer CJ; Letterio JJ
J Interferon Cytokine Res; 2010 Jul; 30(7):497-508. PubMed ID: 20626291
[TBL] [Abstract][Full Text] [Related]
8. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.
Tran TA; McCoy MK; Sporn MB; Tansey MG
J Neuroinflammation; 2008 May; 5():14. PubMed ID: 18474101
[TBL] [Abstract][Full Text] [Related]
9. The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
Tran K; Risingsong R; Royce D; Williams CR; Sporn MB; Liby K
Cancer Prev Res (Phila); 2012 May; 5(5):726-34. PubMed ID: 22401982
[TBL] [Abstract][Full Text] [Related]
10. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
Ling X; Konopleva M; Zeng Z; Ruvolo V; Stephens LC; Schober W; McQueen T; Dietrich M; Madden TL; Andreeff M
Cancer Res; 2007 May; 67(9):4210-8. PubMed ID: 17483332
[TBL] [Abstract][Full Text] [Related]
11. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.
Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB
Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868
[TBL] [Abstract][Full Text] [Related]
12. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
13. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.
Nagaraj S; Youn JI; Weber H; Iclozan C; Lu L; Cotter MJ; Meyer C; Becerra CR; Fishman M; Antonia S; Sporn MB; Liby KT; Rawal B; Lee JH; Gabrilovich DI
Clin Cancer Res; 2010 Mar; 16(6):1812-23. PubMed ID: 20215551
[TBL] [Abstract][Full Text] [Related]
15. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.
Qin D; Wang W; Lei H; Luo H; Cai H; Tang C; Wu Y; Wang Y; Jin J; Xiao W; Wang T; Ma C; Xu H; Zhang J; Gao F; Wu YL
Oncotarget; 2016 Nov; 7(47):77096-77109. PubMed ID: 27780924
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
[TBL] [Abstract][Full Text] [Related]
17. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.
Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C
Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252
[TBL] [Abstract][Full Text] [Related]
18. Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
Gao X; Liu Y; Deeb D; Arbab AS; Guo AM; Dulchavsky SA; Gautam SC
Anticancer Res; 2011 Nov; 31(11):3673-81. PubMed ID: 22110186
[TBL] [Abstract][Full Text] [Related]
19. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
20. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
